Stockscreener 앱 받기
5.19
2.37%
0.12
전일 마감가:
$5.07
열려 있는:
$5.02
하루 거래량:
211.10K
Relative Volume:
2.97
시가총액:
$3.69M
수익:
$574.20K
순이익/손실:
$-7.15M
주가수익비율:
-0.3269
EPS:
-15.8778
순현금흐름:
$-7.00M
1주 성능:
-1.52%
1개월 성능:
-21.00%
6개월 성능:
-54.67%
1년 성능:
-78.60%
1일 변동 폭
$4.95
$5.34
1주일 범위
$4.86
$5.505
52주 변동 폭
$1.41
$29.45
애틀론 메디컬 Stock (AEMD) Company Profile
명칭
Aethlon Medical Inc
전화
619-941-0360
주소
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
5.19 | 3.69M | 574.20K | -7.15M | -7.00M | -15.88 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
애틀론 메디컬 Stock (AEMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 재개 | H.C. Wainwright | Neutral |
애틀론 메디컬 주식(AEMD)의 최신 뉴스
Form 4 Aethlon Medical Inc: Steven P. Larosa (Chief Medical Officer) For: 8 October - Investing.com Nigeria
Form 4 Aethlon Medical Inc: Angela Rossetti (Director) For: 17 April - Investing.com Nigeria
Form 4 Aethlon Medical Inc: Nicolas Gikakis (Director) For: 30 September - Investing.com Nigeria
Form 4 Aethlon Medical Inc: Edward G. Broenniman (Director) For: 30 September By Investing.com - Investing.com South Africa
JANE STREET GROUP, LLC Expands Aethlon Medical Inc (AEMD) Stake with 28,043-Share Purchase - GuruFocus
Jane Street Group Reports 5% Ownership Stake in Aethlon Medical Inc - Kalkine Media
Two Jane Street subsidiaries report stakes in Aethlon Medical (AEMD). - Stock Titan
Aethlon Medical Expands Authorized Common Stock Capacity - The Globe and Mail
Certain Common Stock of Aethlon Medical, Inc. are subject to a Lock-Up Agreement Ending on 6-OCT-2026. - www.marketscreener.com
Aethlon Medical Company Profile & Introduction - Moomoo
Aethlon Medical Corrects 8-K: Preferred Stock Proposal Rejected by Shareholders - Minichart
Form 8K Aethlon Medical Inc For: 1 October By Investing.com - Investing.com Nigeria
Aethlon Medical shareholders approve equity plan amendments and board elections - Investing.com
AEMD: All proposals except preferred stock authorization were approved, with no stockholder questions - TradingView
Aethlon Medical (NasdaqCM:AEMD) Stock Forecast & Analyst Predictions - Simply Wall Street
North Immunology, Aethlon Merge to Advance NOR-101 for AD - Dermatology Times
What Does Aethlon Medical (NASDAQ:AEMD) Reveal About Penny Stocks? - Kalkine Media
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD) - PR Newswire
Aethlon Stock Pulls Back: What's Going On? - Benzinga
Aethlon Medical stock merger with North Immunology, H.C. Wainwright holds neutral - Investing.com
Aethlon Medical Q1 2027 Earnings Call Transcript - Benzinga
Aethlon Stock Pulls Back: What's Going On? - TradingView
Client and Medical Therapeutic Company Aethlon Medical Announces Merger With North Immunology - Procopio
Aethlon Medical To Merge With North Immunology And Raise $180 Million To Advance Atopic Dermatitis Drug NOR-101 - Pulse 2.0
North Immunology to go public via Aethlon reverse merger backed by USD 180m PIPE - AllSci
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Roundup: Orbis Enters $1.4 Billion Partnership with Novo, Dualitas Therapeutics Enters Research collaboration with Roche, Aethlon Medical Merges with North Immunology - Pharmaceutical Executive
Aethlon Medical Shares Surge Over 400% After Announcing North Immunology Merger - Yahoo Finance
North Immunology deal makes Aethlon (NASDAQ: AEMD) a minority owner - Stock Titan
$180 million fuels Aethlon Medical (NASDAQ: AEMD) merger built around a new skin-disease antibody - Stock Titan
Aethlon Medical stock soars over 400% on North Immunology merger deal - Investing.com
Aethlon Medical (AEMD) Announces Merger with North Immunology, M - GuruFocus
Aethlon Medical, Inc. (NASDAQ:AEMD) To Merge With North Immunology; $180M Financing - TradingView
Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis - Yahoo Finance
Why Did Aethlon Medical Stock Jump 4X on Thursday?Aethlon Medical (NASDAQ:AEMD) - benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com
AEMD Stock Alert: Halper Sadeh LLC is Investigating Whether Aethlon Medical, Inc. is Obtaining a Fair Price for its Shareholders - Business Wire
Aethlon Medical Stock Short Interest Rises to 65.04% - Quiver Quantitative
Aethlon Medical | DEFA14A: Others - Moomoo
Aethlon Medical (NASDAQ: AEMD) Schedules October 1 Vote on Major Stock Issuance and Equity Plan Expansion - kalkinemedia.com
Aethlon Medical (NASDAQ: AEMD) Confirms 1.6 Million Shares Outstanding After Full Exercise of Pre-Funded Warrants - kalkinemedia.com
Aethlon Medical (AEMD) Drops 18.88% to $2.02: Key Support Level in FocusSocial Sentiment - vinanet.vn
Aethlon Medical (AEMD) Drops 18.88% to $2.02: Key Support Level in FocusStop Loss Guidance - siam.in
Aethlon Medical Completes Warrant Exercises, Clarifying Capitalization - TipRanks
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Aethlon Medical surges as recent clinical progress meets a very small post-split float - Quiver Quantitative
AEMD Stock Slides As Traders Eye Hemopurifier And Q1 Call - StocksToTrade
AEMD Stock Pulls Back As Traders Eye Q1 Earnings And Hemopurifier Focus - timothysykes.com
AEMD Stock Slides As Traders Eye Q1 Results And Conference - StocksToTrade
애틀론 메디컬 (AEMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
11.21%
자본화:
|
볼륨(24시간):